Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple daily moves may reverse Age-Related muscle decline

NCT ID NCT07494916

Symptom relief Sponsor: Universidad de Granada Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a 12-week program of functional task training (like standing up, walking, and carrying objects) can improve muscle strength and daily function in older adults with sarcopenia. 30 people aged 60 and older will be randomly assigned to different exercise groups. The goal is to see which type of training works best for improving muscle health and physical performance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants aged 60 years or older. Diagnosis of probable or confirmed sarcopenia (according to EWGSOP2 criteria, including low handgrip strength and/or low muscle mass). Ability to walk independently (with or without assistive devices). Medically cleared to participate in a structured physical exercise program. Voluntary participation and signed informed consent. Exclusion Criteria: Unstable cardiovascular disease, uncontrolled hypertension, or any medical condition where exercise is contraindicated. Recent bone fractures or major surgeries within the last 6 months that limit physical activity. Severe visual or auditory deficits that interfere with the training sessions. Concurrent participation in another structured resistance training or functional exercise program. Any musculoskeletal or neurological condition that prevents the safe use of the Functional Electromechanical Dynamometer (DEMF)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aging Muscle weakness | patient Physical functional performance Sarcopenia

Contacts and locations

Locations

  • Lab. IDAFISAD CTS 642 Faculty of Sports Science, Granada

    Granada, Granada, 18006, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.